Antidepressant Withdrawal: A Clinician’s Middle View
Mad in America
OCTOBER 31, 2023
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. Their protests to the contrary have even been seen as indications of a personality disorder.
123 
Let's personalize your content